Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Documented concern — monitor and disclose
Clinically relevant documented concern. Disclose the supplement to your clinician and keep monitoring in place.
Mechanism and evidence
Ginseng has been reported to lower postprandial glucose in controlled studies; combined with sulfonylureas the risk of hypoglycemia becomes clinically relevant because this class forces insulin release regardless of glucose level.
Evidence tier: pharmacology-standard
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Tell your prescriber if you take ginseng alongside a sulfonylurea.
- Watch for symptoms of low blood sugar.
← All reviewed pairs for Sulfonylureas (glimepiride, gliclazide, glibenclamide)